Invesco Ltd. Lowers Holdings in Teladoc Health, Inc. $TDOC

Invesco Ltd. trimmed its position in Teladoc Health, Inc. (NYSE:TDOC) by 4.2% in the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 279,780 shares of the health services provider’s stock after selling 12,143 shares during the quarter. Invesco Ltd. owned 0.16% of Teladoc Health worth $2,227,000 at the end of the most recent reporting period.

Other hedge funds have also made changes to their positions in the company. Cambridge Investment Research Advisors Inc. lifted its holdings in shares of Teladoc Health by 60.8% in the 1st quarter. Cambridge Investment Research Advisors Inc. now owns 39,738 shares of the health services provider’s stock worth $316,000 after buying an additional 15,030 shares during the period. Golden State Wealth Management LLC lifted its holdings in shares of Teladoc Health by 102.6% in the 1st quarter. Golden State Wealth Management LLC now owns 3,337 shares of the health services provider’s stock worth $27,000 after buying an additional 1,690 shares during the period. Wedmont Private Capital lifted its holdings in shares of Teladoc Health by 20.3% in the 1st quarter. Wedmont Private Capital now owns 16,086 shares of the health services provider’s stock worth $117,000 after buying an additional 2,715 shares during the period. Wealth Enhancement Advisory Services LLC lifted its holdings in shares of Teladoc Health by 22.1% in the 4th quarter. Wealth Enhancement Advisory Services LLC now owns 14,725 shares of the health services provider’s stock worth $134,000 after buying an additional 2,662 shares during the period. Finally, Vontobel Holding Ltd. lifted its holdings in shares of Teladoc Health by 61.4% in the 1st quarter. Vontobel Holding Ltd. now owns 21,422 shares of the health services provider’s stock worth $171,000 after buying an additional 8,152 shares during the period. 76.82% of the stock is currently owned by hedge funds and other institutional investors.

Teladoc Health Trading Down 1.9%

Shares of NYSE:TDOC opened at $7.74 on Friday. The business’s 50-day moving average is $7.81 and its 200 day moving average is $8.03. Teladoc Health, Inc. has a 1 year low of $6.35 and a 1 year high of $15.21. The firm has a market capitalization of $1.37 billion, a P/E ratio of -6.50 and a beta of 1.76. The company has a debt-to-equity ratio of 0.70, a current ratio of 2.67 and a quick ratio of 2.58.

Teladoc Health (NYSE:TDOC) last announced its earnings results on Tuesday, July 29th. The health services provider reported ($0.19) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.27) by $0.08. Teladoc Health had a negative return on equity of 10.13% and a negative net margin of 8.16%.The company had revenue of $631.90 million for the quarter, compared to analyst estimates of $621.91 million. During the same period in the prior year, the company posted ($0.38) EPS. The firm’s quarterly revenue was down 1.6% compared to the same quarter last year. Teladoc Health has set its Q3 2025 guidance at -0.350–0.200 EPS. FY 2025 guidance at -1.350–1.000 EPS. On average, research analysts predict that Teladoc Health, Inc. will post -1.16 earnings per share for the current fiscal year.

Analyst Ratings Changes

TDOC has been the subject of a number of analyst reports. Mizuho initiated coverage on Teladoc Health in a research note on Friday, July 25th. They set a “neutral” rating and a $10.00 price objective for the company. Evercore ISI upped their price objective on Teladoc Health from $7.00 to $8.00 and gave the stock an “in-line” rating in a research note on Wednesday, July 9th. Wells Fargo & Company decreased their price objective on Teladoc Health from $10.00 to $8.00 and set an “equal weight” rating for the company in a research note on Thursday, May 8th. Bank of America decreased their price objective on Teladoc Health from $8.00 to $7.00 and set a “neutral” rating for the company in a research note on Wednesday, May 28th. Finally, Truist Financial decreased their price objective on Teladoc Health from $10.00 to $9.00 and set a “hold” rating for the company in a research note on Tuesday, May 27th. Six equities research analysts have rated the stock with a Buy rating and eleven have assigned a Hold rating to the company. Based on data from MarketBeat, the stock presently has an average rating of “Hold” and a consensus price target of $9.80.

Insider Activity at Teladoc Health

In other news, insider Adam C. Vandervoort sold 5,808 shares of the stock in a transaction dated Monday, June 2nd. The stock was sold at an average price of $6.86, for a total value of $39,842.88. Following the transaction, the insider directly owned 69,773 shares of the company’s stock, valued at approximately $478,642.78. This represents a 7.68% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, insider Carlos Nueno sold 3,958 shares of the stock in a transaction dated Monday, June 2nd. The shares were sold at an average price of $6.86, for a total value of $27,151.88. Following the completion of the transaction, the insider directly owned 17,645 shares in the company, valued at $121,044.70. This represents a 18.32% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 18,656 shares of company stock valued at $128,189 in the last ninety days. Corporate insiders own 0.58% of the company’s stock.

About Teladoc Health

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.